CXCR6 is required for antitumor efficacy of intratumoral CD8<sup>+</sup> T cell

Binglin Wang(Nanjing University), Yang Sun(Nanjing University)
Journal for ImmunoTherapy of Cancer
August 1, 2021
Cited by 104


Related Papers